Robert Schrock, PhD
Senior Director, Global Head of Development Services, CGT, Lonza
• Robert Schrock, Ph.D. earned his doctorate in Biochemistry from Vanderbilt School of Medicine.
• After his postdoctoral training at UCSF, he worked at Introgen Therapeutics developing novel Adenovirus gene therapy vectors.
• From 2001-2018, Robert was Head of Quality Control at Introgen, Vivante GMP Solutions and Lonza Houston. Vivante was acquired by Lonza in 2010.
• In 2018 Robert transitioned to Analytical Development as Head of Bioassay Services.
• In 2024 Robert became Sr Director, Global Head of Development Services. He is responsible for Process and Analytical Development at Lonza’s CGT sites in Houston, Geleen (Netherlands) and Siena (Italy).